Together, the functional significance of MUC16 and MUC16-Cter in PC and NSCLC, coupled with the availability of a novel mAb5E6 directed towards the MUC16-Cter domain, rationalize evaluating this mAb for therapeutic utility31. The gene discussed is MUC16; the disease is non-small cell lung carcinoma.